Once MM was established, recipients were divided into 4 groups with comparable gamma-globulin to albumin (G/A) ratios and similar complete blood count (CBC) parameters and treated with vehicle, Tra, Pon, and combined Tra and Pon (Figs. 3A and S8). The gene discussed is ALB; the disease is Miyoshi myopathy.